Identify high-risk members before they deteriorate
The PhysioSense Platform gives health plans and care management teams a continuous, physiologically grounded signal for cardiovascular risk — enabling proactive intervention, reduced readmissions, and measurable cost savings.
Standard risk scores miss the patients who matter most
Claims-based models are retrospective, lag by months, and cannot detect the physiological precursors of acute events. Members with normal labs and stable vital signs can still be in compensated hemodynamic decline.
- Heart failure readmissions frequently occur within 30 days of discharge — often in members flagged as “stable” at follow-up
- CKD progression to end-stage renal disease correlates with vascular stiffening detectable months before eGFR decline
- Dementia-associated cardiovascular signatures appear in waveform data well before cognitive symptom onset
- Hypertension treatment response varies widely — standard BP targets miss many non-responders
A new physiological input for member engagement and care management
Through the PulseVu app, PhysioSense enables payers to add a simple smartphone-based physiological check-in to member programs — improving engagement while giving care teams a new longitudinal signal for follow-up and prioritization.
Where PhysioSense creates value for health plans
From chronic disease management to post-acute transitions, PhysioSense derived signals layer onto existing care programs with minimal workflow disruption.
CHF Readmission Prevention
Early hemodynamic compensation is detectable in PPG waveforms before clinical decompensation. PhysioSense identifies members whose vascular load and compliance are shifting — triggering timely outreach, medication titration, or escalation before a 911 call or ER visit.
CKD Progression Monitoring
Arterial stiffening — a hallmark of CKD-associated cardiovascular disease — is captured in waveform-derived compliance measures months before eGFR-based staging moves. PhysioSense enables earlier nephrology referral and cardiac co-management, protecting both kidneys and outcomes.
Cognitive Risk & Vascular Dementia
Vascular contributions to dementia are measurable in peripheral waveform signals. PhysioSense provides a cardiovascular risk layer complementary to cognitive assessments, informing prevention program enrollment.
Hypertension Treatment Response
BP targets alone are insufficient — vascular compliance and load responses to antihypertensives vary substantially by phenotype. PhysioSense identifies the physiological subgroup of each member, enabling precision titration rather than protocol-driven escalation.
Diabetic Cardiovascular Stratification
Cardiovascular disease is the leading cause of mortality in type 2 diabetes. PhysioSense vascular phenotyping stratifies diabetic members by actual hemodynamic risk — enabling targeted SGLT2i/GLP-1 enrollment, preventive cardiology referral, and care plan intensification for truly high-risk individuals.
Discharge-to-Home Monitoring
The 30-day window post-hospitalization is the highest-risk period for readmission. PhysioSense’s remote monitoring module provides a physiological early-warning layer during this transition — integrated with existing care coordination workflows and EHR messaging for nurse follow-up triggers.
Clinical evidence aligned to earlier follow-up and better prioritization
PhysioSense waveform analysis has shown the ability to detect meaningful physiological differences and trends across acute, chronic, and treatment-response settings relevant to care management.
Early Physiological Instability Detection
In acute-care and monitored patient populations, PhysioSense-derived physiological markers tracked hemodynamic deterioration patterns that were not fully reflected in routine vitals alone. This supports the ability to identify concerning change earlier and improve prioritization before overt clinical decline.
Longitudinal Vascular Change Across Chronic Conditions
Across multiple cohorts, PhysioSense detected vascular compliance and related waveform differences associated with chronic cardiovascular, renal, and neurovascular burden. These findings support use in longitudinal tracking programs where subtle physiological drift may matter before conventional triggers are reached.
Response and Recovery Tracking
Serial waveform analysis before and after clinical interventions showed directional physiological change consistent with known treatment and recovery effects. This supports use in follow-up workflows where care teams need added visibility into whether a member appears to be stabilizing, improving, or drifting.
How health plans engage with PhysioSense
We typically work with health plans in a phased collaboration model — combining our physiological signal expertise with the payer’s care management, clinical, and member engagement expertise to identify high-impact opportunities, test them quickly, and scale what works, typically starting with a 10-week opportunity identification and prototyping engagement.
Opportunity Identification
Jointly identify the member populations and workflows where physiological insight could add the most value — such as post-discharge follow-up, chronic condition monitoring, medication response, or care prioritization.
Prototype & Business Case
Define the member experience, care team workflow, operational triggers, and success metrics. Rapidly prototype, leveraging PulseVu and PhysioSense technologies, and develop the business case before broader deployment.
Pilot Deployment
Launch prototype within a defined member cohort to evaluate engagement, longitudinal physiological trends, workflow fit, and incremental value for care management teams.
Rollout & Measurement
Expand to additional populations and programs based on pilot results, with ongoing measurement of member engagement, prioritization efficiency, and selected clinical or operational outcomes.
A collaborative model for payer innovation
PhysioSense brings the physiological signal science and PulseVu experience layer, while payer partners bring the clinical, operational, and member-management context needed to target the right use cases and deploy them effectively.
- PhysioSense: physiological signal interpretation, PulseVu workflows, prototype design, and pilot support
- Payer partner: target populations, care pathways, outreach strategy, and program success criteria
- Together: define the use case, build the workflow, test adoption, and measure impact
- Engagements can begin with a focused pilot and expand into broader member programs based on results
- PulseVu can be configured to fit different member engagement and care management models
- Program design can emphasize member usability, care team visibility, or integration into existing workflows depending on the opportunity
Ready to identify the right pilot opportunity?
Meet with our team to review your highest-priority member populations and explore a focused 10-week opportunity identification and prototyping engagement.
Schedule a Pilot Discussion